http://www.fpnotebook.com/
Valproate
Aka: Valproate, Valproic Acid, Depakote, Depakene
- Indications
- Generalized Tonic Clonic Seizures
- Absence Seizures
- Myoclonic Seizures
- Simple Partial Seizures
- Complex Partial Seizures
- Migraine Headache Prophylaxis
- Mania
- Contraindications
- Hepatic dysfunction
- Pregnancy
- Urea cycle disorder
- Adverse Effects: Dose related
- Nausea and Vomiting
- Tremor
- Ataxia
- Diarrhea
- Lethargy or Sedation
- Mild Liver Function Test abnormalities (AST, ALT)
- Weight gain
- Adverse Effects
- Pancreatitis
- Alopecia
- Centrum A-Zinc daily prevents associated Hair Loss
- Thrombocytopenia
- Leukopenia
- Stevens-Johnson Syndrome
- Osteoporosis
- Hepatic dysfunction (in rare cases, may be fatal)
- Dosing: Adults
- Seizure Disorder
- Initial: 10-15 mg/kg/day divided daily to three times daily
- Increase in 5-10 mg/kg/day increments weekly
- Target dose: 30-60 mg/kg/day to 1000-2500 mg/day
- Divide regular and delayed release dosing two to four times daily
- Extended release may be dosed once daily
- Migraine Headache Prophylaxis
- Initial
- Depakote ER 500 mg orally daily for 7 days
- Depakote delayed release 250 mg orally twice daily
- May increase to 1000 mg/day
- Bipolar Disorder
- Loading dose in acute mania: 15-20 mg/kg
- Starting dose without load: 500 to 750 mg/day in divided dosing
- Titrate every 2-3 days as tolerated to serum Valproic Acid level of 50 to 125 mcg/ml
- Target dose: 1000 to 3000 mg daily in divided doses
- Drug Interactions
- Numerous drug interactions
- Toxicity
- Large therapeutic window
- Monitoring
- Serum Valproate level
- Initial: Every 1-2 weeks
- Later: Every 3-6 months
- Other routine monitoring
- Obtain monthly for 2 months and then every 3 to 12 months
- Complete Blood Count
- Liver Function Tests
- Pregnancy Risk
- Class D